{"id":"https://openalex.org/W2125212191","doi":null,"title":"Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.","display_name":"Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.","publication_year":2001,"publication_date":"2001-08-01","ids":{"openalex":"https://openalex.org/W2125212191","mag":"2125212191","pmid":"https://pubmed.ncbi.nlm.nih.gov/11489831"},"language":"en","primary_location":{"id":"pmid:11489831","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11489831","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023819954","display_name":"Daming Shan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Shan","raw_affiliation_strings":["Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98195, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98195, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A K Gopal","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023180146","display_name":"Oliver W. Press","orcid":"https://orcid.org/0000-0002-3147-8037","observed_orcids":["https://orcid.org/0000-0002-3147-8037"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O W Press","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5819,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.64347122,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"7","issue":"8","first_page":"2490","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.3686999976634979,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.07370000332593918,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenretinide","display_name":"fenretinide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9350000023841858},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tositumomab","display_name":"tositumomab","score":0.996999979019165},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8799999952316284},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7739999890327454},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.9340000152587891},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.7889999747276306},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7077932357788086},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.694534182548523},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.632435142993927},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6088568568229675},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.5029007792472839},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4950024485588074},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.49208492040634155},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4907778203487396},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4869331121444702},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4867696762084961},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48371556401252747},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4461982250213623},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4436858594417572},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34736132621765137},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3027390241622925},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2557593584060669},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017313","descriptor_name":"Fenretinide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11489831","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11489831","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:2125212191","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11489831","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6880936110","display_name":"OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA","funder_award_id":"K23CA085479","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W21149459","https://openalex.org/W78060682","https://openalex.org/W136104837","https://openalex.org/W147398146","https://openalex.org/W206701898","https://openalex.org/W1512692518","https://openalex.org/W1545071010","https://openalex.org/W1554600230","https://openalex.org/W1593640213","https://openalex.org/W1892184508","https://openalex.org/W1915689252","https://openalex.org/W1927684145","https://openalex.org/W1972023101","https://openalex.org/W1976128207","https://openalex.org/W1983339176","https://openalex.org/W1989589268","https://openalex.org/W2007436659","https://openalex.org/W2025510871","https://openalex.org/W2032423298","https://openalex.org/W2034976273","https://openalex.org/W2057796652","https://openalex.org/W2079756029","https://openalex.org/W2098860085","https://openalex.org/W2100321375","https://openalex.org/W2104940816","https://openalex.org/W2145743858","https://openalex.org/W2154015002","https://openalex.org/W2157222653","https://openalex.org/W2157226695","https://openalex.org/W2165675012","https://openalex.org/W2167599338","https://openalex.org/W2168926834","https://openalex.org/W2176061808","https://openalex.org/W2321951461","https://openalex.org/W2331308267","https://openalex.org/W2403241322","https://openalex.org/W2468222881"],"related_works":["https://openalex.org/W2089230581","https://openalex.org/W2130031341","https://openalex.org/W2053893225","https://openalex.org/W2164455849","https://openalex.org/W2060968698","https://openalex.org/W2183498931","https://openalex.org/W2009205752","https://openalex.org/W2468222881","https://openalex.org/W2077132003","https://openalex.org/W2149422028"],"abstract_inverted_index":{"Retinoids":[0],"have":[1,39],"been":[2,41],"shown":[3,42],"to":[4,22,43,55,70,130,150,226],"be":[5,23,56,179],"clinically":[6],"useful":[7],"in":[8,27,49,86,98,210,235,242,260],"the":[9,85,107,170,200,240,251,261],"biological":[10],"therapy":[11],"of":[12,46,89,109,114,137,188,192,197,212,215,230,245,256,263],"certain":[13],"myeloid":[14],"and":[15,35,63,94,117,145,153,199,204,220],"T-cell":[16],"malignancies,":[17],"whereas":[18,66],"CD20":[19,67],"has":[20],"proven":[21],"an":[24],"effective":[25],"target":[26],"B-cell":[28,99,139,264],"lymphoma":[29,100],"immunotherapy.":[30],"Both":[31],"retinoic":[32],"acid":[33,116],"derivatives":[34],"anti-CD20":[36,96,201,257],"monoclonal":[37,258],"antibodies":[38,97,202,259],"also":[40,121],"induce":[44],"apoptosis":[45,52,213],"malignant":[47,110,138],"cells":[48],"vitro.":[50],"Retinoid-induced":[51],"is":[53,128,132,154],"thought":[54],"mediated":[57],"by":[58,181],"nuclear":[59],"retinoid":[60],"receptor":[61],"binding":[62],"transcriptional":[64],"activation,":[65],"ligation":[68],"appears":[69],"initiate":[71],"transmembrane":[72],"Ca(2+)":[73],"influx":[74],"with":[75,93,156,164],"resultant":[76],"programmed":[77],"cell":[78],"death.":[79],"In":[80],"this":[81,124],"report,":[82],"we":[83,167],"evaluate":[84],"vitro":[87,236],"effects":[88],"N-(4-hydroxyphenyl)":[90],"retinamide":[91],"(4-HPR)":[92],"without":[95],"lines.":[101],"We":[102,120],"demonstrate":[103],"that":[104,113,123,169,177,239],"4-HPR":[105,198],"inhibits":[106],"growth":[108,126],"B-cells":[111],"beyond":[112],"all-trans-retinoic":[115],"13-cis-retinoic":[118],"acid.":[119],"show":[122,168],"4-HPR-mediated":[125],"inhibition":[127],"attributable":[129],"apoptosis,":[131,166],"consistent":[133],"across":[134],"a":[135,185,193,207],"variety":[136],"lines":[140],"(Ramos,":[141],"Ramos":[142],"AW,":[143],"SU-DHL4,":[144],"Raji),":[146],"peaks":[147],"at":[148],"96":[149],"144":[151],"h,":[152],"attainable":[155],"concentrations":[157],"as":[158,160],"low":[159],"2":[161,194],"microM.":[162],"As":[163],"CD20-mediated":[165],"final":[171],"common":[172],"pathway":[173],"includes":[174],"caspase":[175,189],"activation":[176],"can":[178],"blocked":[180],"2-val-Ala-Asp-fluoromethyl":[182],"ketone":[183],"(z-VAD),":[184],"specific":[186],"inhibitor":[187],"function.":[190],"Coincubation":[191],"microM":[195],"concentration":[196],"rituximab":[203],"tositumomab":[205],"exhibited":[206],"supra-additive":[208],"increase":[209],"levels":[211,229],"induction":[214],"24%":[216],"(P":[217,222],"=":[218,223],"0.009)":[219],"42%":[221],"0.0019)":[224],"relative":[225],"expected":[227],"additive":[228],"these":[231,246],"same":[232],"agents.":[233],"These":[234],"findings":[237],"suggest":[238],"potential":[241],"vivo":[243],"synergy":[244],"well-tolerated":[247],"drugs":[248],"may":[249],"augment":[250],"previously":[252],"demonstrated":[253],"clinical":[254],"activity":[255],"treatment":[262],"malignancies.":[265]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}